
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Shares | 97.94 | 97.94 | 0.00 |
Other | 2.10 | 2.10 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 16.28 | 19.12 |
Price to Book | 4.53 | 4.32 |
Price to Sales | 6.64 | 2.42 |
Price to Cash Flow | 17.03 | 16.66 |
Dividend Yield | 1.34 | 1.14 |
5 Years Earnings Growth | 7.48 | 12.09 |
Number of long holdings: 95
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AbbVie | US00287Y1091 | 23.23 | 183.09 | -1.42% | |
Amgen | US0311621009 | 7.83 | 278.40 | -0.38% | |
Gilead | US3755581036 | 7.47 | 108.44 | -0.60% | |
Regeneron Pharma | US75886F1075 | 7.34 | 591.85 | -1.89% | |
Alnylam | US02043Q1076 | 6.12 | 285.56 | -1.56% | |
Ascendis Pharma AS | US04351P1012 | 4.87 | 159.24 | +1.25% | |
argenx ADR | US04016X1019 | 4.17 | 576.24 | -0.61% | |
Nuvalent Inc Class A | - | 2.08 | - | - | |
Xenon Pharmaceuticals | CA98420N1050 | 1.71 | 28.49 | -3.29% | |
Viridian Therapeutics | US92790C1045 | 1.65 | 13.50 | -3.09% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity 500 Index Institutional Pr | 593.97B | -4.92 | 12.17 | 12.31 | ||
Fidelity Contrafund | 133.44B | -3.29 | 18.13 | 14.54 | ||
Fidelity Total Market Index Instl b | 99.37B | -5.52 | 11.34 | 11.61 | ||
Fidelity International Index Inst | 58.83B | 12.35 | 10.69 | 5.65 | ||
Fidelity Blue Chip Growth | 54.71B | -12.53 | 16.00 | 16.01 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review